Two cases involving Tennessee children with autism illustrate the harsh, complex realities they face in the juvenile justice ...

The Arizona State Schools for the Deaf and the Blind will no longer directly provide on-site classes for students who are blind or have low vision and are not also ...

A Gainesville woman, Makeda Evans, sued 49 businesses, including 43 in Alachua County, for failing to comply with ADA ...

Cut off from established pathways for managing a chronic illness, many Vermonters with long Covid have reported living in a sort of permanent limbo. They have faced stigma and disbelief from loved ...

Walk around Disneyland or Dollywood during a weekday in, say, early November, and you’ll see school-age children seemingly everywhere. With no school holidays in sight, how could this be? Are they ...

The Paralympics do not include figure skating but there's a movement to change that. Social media is helping figure skaters ...

Universities from Harvard to Hampshire have admitted significantly more students with disabilities over the last decade, as diagnoses for A.D.H.D. and anxiety increase.

Youth and young adults with autism spectrum disorder, intellectual disability, or cerebral palsy experience higher mortality than the general population; causes of death vary widely.

Data on persons with disabilities are hard to come by in almost every country. Specific data on their employment situation are even harder to find. Yet persons with disabilities face the same ...

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in ...

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) – Late-breaking Phase III FENtrepid ...

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK inhibitor to a 12% reduction in the risk of disability progression compared to ...